tradingkey.logo
tradingkey.logo
검색

Labcorp Holdings Inc

LH
관심 목록에 추가
271.470USD
0.0000.00%
종가 06/26, 16:00ET시세는 15분 지연됩니다
22.34B시가총액
23.89P/E TTM

자세한 내용은 Labcorp Holdings Inc 회사

Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.

Labcorp Holdings Inc 정보

종목 코드 LH
회사 이름Labcorp Holdings Inc
상장일Apr 24, 1991
CEOSchechter (Adam H)
직원 수70000
유형Ordinary Share
회계 연도 종료Apr 24
주소358 S Main St
도시BURLINGTON
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호27215
전화13362291127
웹사이트https://www.labcorp.com/
종목 코드 LH
상장일Apr 24, 1991
CEOSchechter (Adam H)

Labcorp Holdings Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
107.23K
-5.50%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
36.49K
+17.78%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+8.75%
Mr. Mark S. Schroeder
Mr. Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
15.04K
+56.95%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
13.78K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Director
Lead Independent Director
13.74K
--
Ms. Kerrii B. Anderson, CPA
Ms. Kerrii B. Anderson, CPA
Independent Director
Independent Director
9.85K
+2.92%
Ms. Amy B. Summy
Ms. Amy B. Summy
Executive Vice President, Chief Marketing Officer
Executive Vice President, Chief Marketing Officer
7.88K
+27.39%
Ms. Sandra Dillard van Der Vaart
Ms. Sandra Dillard van Der Vaart
Executive Vice President, Chief Legal Officer, and Corporate Secretary
Executive Vice President, Chief Legal Officer, and Corporate Secretary
5.82K
+62.94%
Ms. Anita Z. Graham
Ms. Anita Z. Graham
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
5.18K
+71.84%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
107.23K
-5.50%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
36.49K
+17.78%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+8.75%
Mr. Mark S. Schroeder
Mr. Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
15.04K
+56.95%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
13.78K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Director
Lead Independent Director
13.74K
--

자주 묻는 질문

Labcorp Holdings Inc의 상위 5대 주주는 누구인가요?

Labcorp Holdings Inc의 상위 5대 주주는 다음과 같습니다: Mr. Adam H. Schechter

Labcorp Holdings Inc(LH)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Labcorp Holdings Inc의 주식을 보유한 기관은 총 1855곳이며, 이들이 보유한 주식의 총 가치는 약 88.74M로 전체 발행 주식의 108.22%를 차지합니다. 이는 2025Q4 대비 5570263.00 증가한 수치입니다.
KeyAI